Enoxaparin in Treatment of Vascular Intra-Uterine Growth Retardatio
Phase 3
Recruiting
- Conditions
- Intra-uterine growth retardation.
- Registration Number
- IRCT20180819040830N4
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 126
Inclusion Criteria
>18 years old women with singleton pregnant women
Diagnosis of intra-uterine growth retardation for their fetus
Exclusion Criteria
Maternal age <18 years old
Multiple pregnanvy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Birth weight. Timepoint: At delivery time. Method of measurement: Measuring neonatal birth weight by an electronic scale.
- Secondary Outcome Measures
Name Time Method Enoxaparin side effects (including active bleeding due to enoxaparine use or thrombocytopena after beginning the enoxaparin. Timepoint: Any time after beginning the study. Method of measurement: History taking, physical exam, laboratory test.